These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4431311)

  • 1. [Results of liver biopsies during the treatment of silicosis using polyvinylpyridine-N-oxide (PVNO) in man].
    Haas P; Huber W
    Med Welt; 1974 Oct; 25(42):1707-9. PubMed ID: 4431311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P; Huber W
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
    Prügger F; Mallner B; Schlipköter HW
    Wien Klin Wochenschr; 1984 Dec; 96(23):848-53. PubMed ID: 6396971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [P 204 for prevention and treatment of silicosis].
    Pfeiffer W
    Munch Med Wochenschr; 1968 Mar; ():Suppl 13:1-2. PubMed ID: 5695461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of polyvinylpyridine-N-oxide on matured experimental silicosis in the liver-spleen test].
    Heeren E; Eger W; Einbrodt HJ
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):137-50. PubMed ID: 5171409
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis.
    Zhao JD; Liu JD; Li GZ
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Oct; 178(3):259-62. PubMed ID: 6659745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyvinylpyridine-N-oxide. (Review)].
    Dubovik BV; Shadurskiĭ KS; Etlis VS
    Farmakol Toksikol; 1969; 32(2):226-31. PubMed ID: 4893594
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of tetrandrine (TT) and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and type III collagens during experimental silicosis.
    Liu BC; He YX; Miao Q; Wang HH; You BR
    Biomed Environ Sci; 1994 Sep; 7(3):199-204. PubMed ID: 7848548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effectiveness of polyvinoxide in silicosis and silicotuberculosis].
    Zislin DM; Gol'del'man AG; Katsnel'son BA; Tikhotskaia LI; Rassokhina TG
    Gig Tr Prof Zabol; 1985 Nov; (11):21-5. PubMed ID: 4085887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
    Bogdanskaia NI
    Gig Tr Prof Zabol; 1973 May; 17(5):22-5. PubMed ID: 4771393
    [No Abstract]   [Full Text] [Related]  

  • 11. A biochemical study on combined treatment of experimental silicosis with tetradrine-PVNO and tetradrine-QOHP in rats.
    Yu L; Zhou CQ; Li YR; Qu L; Xing KJ; Du QC
    Biomed Environ Sci; 1995 Sep; 8(3):265-8. PubMed ID: 8561927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis].
    Rodkina BS; Bolonova LN
    Farmakol Toksikol; 1979; 42(1):81-4. PubMed ID: 421895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI; Tolgskaia MS
    Gig Sanit; 1973 Apr; 38(4):102-4. PubMed ID: 4731236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of serum polyvinylpyridine-N-oxide after intravenous administration in silicosis patients].
    Grünspan M; Antweiler H; Marcic I
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):101-13. PubMed ID: 5171408
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trials of casual treatment of silicosis].
    Idec-Sadkowska I; Andrzejak R; Antonowicz-Juchniewicz J; Kaczmarek-Wdowiak B
    Med Pr; 2006; 57(3):271-80. PubMed ID: 17125034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
    Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
    Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of silicosis].
    Fritze E
    Dtsch Med Wochenschr; 1968 May; 93(19):961-3. PubMed ID: 5650005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
    Dubovik BV; Shadurskiĭ KS; Etlis VS; Lushnikova GA; Shevchuk AS
    Farmakol Toksikol; 1971; 34(3):352-7. PubMed ID: 5568700
    [No Abstract]   [Full Text] [Related]  

  • 19. [Animal experimental fundamentals in the medicinal prevention of silicosis using polyvinylpyridine-N-oxide (P204)].
    Pott F; Schlipköter HW; Brockhaus A
    Dtsch Med Wochenschr; 1968 Dec; 93(51):2479-82. PubMed ID: 5724499
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of wedge and needle hepatic biopsy in open bariatric surgery.
    Padoin AV; Mottin CC; Moretto M; Berleze D; Kupski C; Glock L; Reichel CL; da Silva VD; da Silva JB
    Obes Surg; 2006 Feb; 16(2):178-82. PubMed ID: 16469220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.